Search database
Filter
176
Text search: counterfeit drug
Featured
Language
Document type
93
36
23
9
8
3
3
1
Countries / Regions
10
10
8
7
7
6
5
5
4
4
4
4
4
4
3
3
3
3
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
26
10
4
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Publication Years
Category
94
8
6
5
4
1
1
Toolboxes
30
27
7
6
5
4
2
2
2
2
2
1
1
1
1
1
1
A survey was conducted in countries in all six WHO regions and focused on the building blocks that are considered prerequisites to combat antimicrobial resistance: a comprehensive national plan, laboratory capacity to undertake surveillance for resistant microorganisms, access to safe, effective ant ... more
This manual has been developed to guide rapid risk assessment of acute public health risks from any type of hazard in response to requests from Member States of the World Health Organization (WHO). The manual is aimed primarily at national departments with health-protection responsibilities, Nationa ... more

Haiti Pharmaceutical Sector Technical Assistance Priorities: Technical Report

Sameh Saleeb, Seydou Doumbia United States Agency for International Development (USAID), SIAPS (2012) CC
A series of tools and templates have been developed by WHO, FAO and OIE to accompany the manual for developing national action plans on antimicrobial resistance

Improving Access to and Appropriate Use of Medicines for Mental Disorders

Corrado Barbui, Tarun Dua, Kavitha Kolappa et al. World Health Organization and Calouste Gulbenkian Foundation (2017) C_WHO
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
Act 9 of 2016
Accessed November 2017